The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Diurnal Group Names Director Sam Williams Interim Chair

Thu, 05th Mar 2020 17:21

(Alliance News) - Diurnal Group PLC on Thursday said Non-Executive Director Sam William will assume the role of interim chair, effective from June 30.

Diurnal's current Non-Executive Chair Peter Allen will step down at the end of June, after a five-year stint.

Williams is the board representative of IP Group PLC, which holds a significant stake in Diurnal. He has over 20 years of experience in the biotechnology industry, both as a top-ranked equity analyst in the city and as an investor and chief executive, the pharmaceutical company said.

He has been on the board of Diurnal since 2015 and held the role of interim chairman prior to the appointment of Allen. He will temporarily replace Allen until a permanent successor is found.

"I would like to thank Peter for his considerable contribution to the company during the past five years. His extensive experience and wise counsel have been invaluable. He leaves Diurnal well-positioned to achieve its vision of becoming a world-leading specialty endocrinology company. We wish him the very best for the future," said Chief Executive Martin Whitaker.

Diurnal shares closed 2.8% lower at 32.45 pence each on Thursday in London.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
28 Oct 2022 21:18

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

21 Oct 2022 21:29

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

14 Oct 2022 15:48

UK shareholder meetings calendar - next 7 days

7 Oct 2022 13:01

Diurnal treatment gets approval from Welsh regulatory body

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hy...

7 Oct 2022 11:31

Diurnal's 'Efmody' treatment gets thumbs-up for NHS Wales

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommen...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.